What is the best approach for defining patient services strategy for premium treatments in emerging, out-of-pocket markets?
Specialized “premium” therapy sales in growth markets is a strategic focus in the industry, and patient services offerings play an increasing role in achieving this goal. The development of patient programs in developing countries requires calibration to nuances of the local context, particularly for out-of-pocket markets.
What is the best approach for defining patient services strategy for premium treatments in emerging, out-of-pocket markets?
This white paper has been written by our consultants Kevin Maples and Francesca Schneller
Share
See also

Articles
Observia's broadcast for European e-health in 2023

Success Stories
The complex journey of women living through menopause syndrome
Press / Media
New study results show SPUR™ tool predicts hospital admission and early readmission
Need more information?
A burning question, a specific request, a great project to share with us? Get in touch, our teams are here to help!
